Skip to main content

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

VRNA holding history

Verona Pharma plc in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRNA overviewAll 13F holders of VRNAFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of VRNA by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−1,575,904−100.0%Sold outHolders
Q3 20251,575,904$168.2M<0.1%+1,393,574+764.3%AddedHolders
Q2 2025182,330$17.2M<0.1%−1,441,797−88.8%ReducedHolders
Q1 20251,624,127$103.1M<0.1%+140,374+9.5%AddedHolders
Q4 20241,483,753$68.9M<0.1%+892,844+151.1%AddedHolders
Q3 2024590,909$17.0M<0.1%−273,122−31.6%ReducedHolders
Q2 2024864,031$12.5M<0.1%+530,859+159.3%AddedHolders
Q1 2024333,172$5.36M<0.1%−148,024−30.8%ReducedHolders
Q4 2023481,196$9.57M<0.1%+407,153+549.9%AddedHolders
Q3 202374,043$1.21M<0.1%−6,885−8.5%ReducedHolders
Q2 202380,928$1.71M<0.1%−124,968−60.7%ReducedHolders
Q1 2023205,896$4.13M<0.1%+34,778+20.3%AddedHolders
Q4 2022171,118$4.47M<0.1%+166,140+3,337.5%AddedHolders
Q3 20224,978$51.0K<0.1%−4,807−49.1%ReducedHolders
Q2 20229,785$41.0K<0.1%+332+3.5%AddedHolders
Q1 20229,453$47.0K<0.1%+2,185+30.1%AddedHolders
Q4 20217,268$48.0K<0.1%−926−11.3%ReducedHolders
Q3 20218,194$45.0K<0.1%+4,520+123.0%AddedHolders
Q2 20213,674$24.0K<0.1%+2,174+144.9%AddedHolders
Q1 20211,500$13.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.